Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Re-expression of cell cycle markers in aged neurons and muscles: Whether cells should divide or die?
Renu Sharma, Dhiraj Kumar, Niraj Kumar Jha, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2016) Vol. 1863, Iss. 1, pp. 324-336
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Age-dependent instability of mature neuronal fate in induced neurons from Alzheimer’s patients
Jérôme Mertens, Joseph R. Herdy, Larissa Traxler, et al.
Cell stem cell (2021) Vol. 28, Iss. 9, pp. 1533-1548.e6
Open Access | Times Cited: 180
Neuronal cell death mechanisms in Alzheimer’s disease: An insight
Parul Goel, Sasanka Chakrabarti, Kapil Goel, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 132
Cell Cycle Deficits in Neurodegenerative Disorders: Uncovering Molecular Mechanisms to Drive Innovative Therapeutic Development
Chitra Joseph, Abubakar Siddiq Mangani, Veer Bala Gupta, et al.
Aging and Disease (2020) Vol. 11, Iss. 4, pp. 946-946
Open Access | Times Cited: 70
Expression of progenitor cell/immature neuron markers does not present definitive evidence for adult neurogenesis
Hideo Hagihara, Tomoyuki Murano, Koji Ohira, et al.
Molecular Brain (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 60
RETRACTED ARTICLE: Codelivery of HIF-1α siRNA and Dinaciclib by Carboxylated Graphene Oxide-Trimethyl Chitosan-Hyaluronate Nanoparticles Significantly Suppresses Cancer Cell Progression
Sepideh Izadi, Asma Moslehi, Hadiseh Kheiry, et al.
Pharmaceutical Research (2020) Vol. 37, Iss. 10
Closed Access | Times Cited: 50
Extrachromosomal Circular DNA: Current Knowledge and Implications for CNS Aging and Neurodegeneration
Quratul Ain, Christian Schmeer, Diane Wengerodt, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2477-2477
Open Access | Times Cited: 48
The Post-amyloid Era in Alzheimer's Disease: Trust Your Gut Feeling
Carolina Osorio, Tulasi Kanukuntla, Eddie Lee Diaz, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 47
Pharmacological relevance of CDK inhibitors in Alzheimer's disease
Nishtha Malhotra, Rohan Gupta, Pravir Kumar
Neurochemistry International (2021) Vol. 148, pp. 105115-105115
Closed Access | Times Cited: 35
A natural product solution to aging and aging-associated diseases
Chuanbin Yang, Wei Zhang, Xiaoduo Dong, et al.
Pharmacology & Therapeutics (2020) Vol. 216, pp. 107673-107673
Closed Access | Times Cited: 35
Integration of Transcriptomics and Non-Targeted Metabolomics Reveals the Underlying Mechanism of Skeletal Muscle Development in Duck during Embryonic Stage
Zhigang Hu, Xiaolin Liu
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5214-5214
Open Access | Times Cited: 11
Tau and DNA Damage in Neurodegeneration
Luca Colnaghi, Diego Rondelli, Marco Muzi-Falconi, et al.
Brain Sciences (2020) Vol. 10, Iss. 12, pp. 946-946
Open Access | Times Cited: 30
HDAC1 dysregulation induces aberrant cell cycle and DNA damage in progress of TDP‐43 proteinopathies
Cheng‐Chun Wu, Lee‐Way Jin, I‐Fang Wang, et al.
EMBO Molecular Medicine (2020) Vol. 12, Iss. 6
Open Access | Times Cited: 29
Unraveling the links between neurodegeneration and Epstein-Barr virus-mediated cell cycle dysregulation
Deeksha Tiwari, Nitish Mittal, Hem Chandra Jha
Current Research in Neurobiology (2022) Vol. 3, pp. 100046-100046
Open Access | Times Cited: 18
New molecular mechanisms to explain the neuroprotective effects of insulin-like growth factor II in a cellular model of Parkinson’s disease
Silvana Y. Romero‐Zerbo, Nadia Valverde, Silvia Claros, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 3
Patient-centered brain transcriptomic and multimodal imaging determinants of clinical progression, physical activity, and treatment needs in Parkinson’s disease
Quadri Adewale, Ahmed Faraz Khan, Sue‐Jin Lin, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access
Unlocking the brain's code: The crucial role of post-translational modifications in neurodevelopment and neurological function
Peng Ye, Wangzheqi Zhang, Yan Liao, et al.
Physics of Life Reviews (2025) Vol. 53, pp. 187-214
Closed Access
Triaging between post-translational modification of cell cycle regulators and their therapeutics in neurodegenerative diseases
Neetu Rani, Mehar Sahu, Rashmi K. Ambasta, et al.
Ageing Research Reviews (2023) Vol. 94, pp. 102174-102174
Closed Access | Times Cited: 9
Targeted proteomic analysis of cognitive dysfunction in remitted major depressive disorder: Opportunities of multi-omics approaches towards predictive, preventive, and personalized psychiatry
Klaus Oliver Schubert, David Stacey, Georgia Arentz, et al.
Journal of Proteomics (2018) Vol. 188, pp. 63-70
Closed Access | Times Cited: 24
α‐Synuclein toxicity in yeast and human cells is caused by cell cycle re‐entry and autophagy degradation of ribonucleotide reductase 1
Belém Sampaio‐Marques, Ana Catarina Guedes, Igor Vasilevskiy, et al.
Aging Cell (2019) Vol. 18, Iss. 4
Open Access | Times Cited: 24
Cyclins, Cyclin-Dependent Kinases, and Cyclin-Dependent Kinase Inhibitors in the Mouse Nervous System
Alice Grison, Suzana Atanasoski
Molecular Neurobiology (2020) Vol. 57, Iss. 7, pp. 3206-3218
Closed Access | Times Cited: 19
Emerging Roles of Inhibitor of Differentiation-1 in Alzheimer’s Disease: Cell Cycle Reentry and Beyond
Shang‐Der Chen, Jenq‐Lin Yang, Yi‐Chun Lin, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1746-1746
Open Access | Times Cited: 19
FOXG1 as a Potential Therapeutic Target for Alzheimer’s Disease with a Particular Focus on Cell Cycle Regulation
Jia Wang, Si-Fei Ma, Qi Yun, et al.
Journal of Alzheimer s Disease (2022) Vol. 86, Iss. 3, pp. 1255-1273
Closed Access | Times Cited: 12
Pervasive Expostulation of p53 Gene Promoting the Precipitation of Neurogenic Convulsions: A Journey in Therapeutic Advancements
Vrinda Gupta, Shareen Singh, Thakur Gurjeet Singh
European Journal of Pharmacology (2024) Vol. 983, pp. 176990-176990
Closed Access | Times Cited: 2
Cell cycle re-entry of neurons and reactive neuroblastosis in Huntington's disease: Possibilities for neural-glial transition in the brain
Nivethitha Manickam, Risna Kanjirassery Radhakrishnan, Jemi Feiona Vergil Andrews, et al.
Life Sciences (2020) Vol. 263, pp. 118569-118569
Closed Access | Times Cited: 17
Deficiency of Parkinson’s Related Protein DJ-1 Alters Cdk5 Signalling and Induces Neuronal Death by Aberrant Cell Cycle Re-entry
María José López-Grueso, C. Alicia Padilla, José Antonio Bárcena, et al.
Cellular and Molecular Neurobiology (2022) Vol. 43, Iss. 2, pp. 757-769
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top